Literature DB >> 23597431

CNS-specific T cells shape brain function via the choroid plexus.

Kuti Baruch1, Michal Schwartz.   

Abstract

Adaptive immunity was repeatedly shown to play a role in maintaining lifelong brain function. Under physiological conditions, this activity was associated with CD4+ T cells specific for brain self-antigens. Nevertheless, direct interactions of T cells with the healthy neuronal parenchyma are hardly detectable. Recent studies have identified the brain's choroid plexus (CP) as an active neuro-immunological interface, enriched with CNS-specific CD4+ T cells. Strategically positioned for receiving signals from both the central nervous system (CNS) through the cerebrospinal fluid (CSF), and from the circulation through epithelium-immune cell interactions, the CP has recently been recognized as an important immunological compartment in maintaining and restoring brain homeostasis/allostasis. Here, we propose that CNS-specific T cells shape brain function via the CP, and suggest this immunological control to be lost as part of aging, in general, and immune senescence, in particular. Accordingly, the CP may serve as a novel target for immunomodulation to restore brain equilibrium.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood-cerebrospinal fluid barrier; CNS-specific T cells; Choroid plexus; Cognitive function; Immunomodulation

Mesh:

Year:  2013        PMID: 23597431     DOI: 10.1016/j.bbi.2013.04.002

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  70 in total

Review 1.  Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.

Authors:  Katarzyna A Dudek; Laurence Dion-Albert; Fernanda Neutzling Kaufmann; Ellen Tuck; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2019-09-13       Impact factor: 3.386

2.  Therapeutic effects of stress-programmed lymphocytes transferred to chronically stressed mice.

Authors:  Rachel B Scheinert; Mitra H Haeri; Michael L Lehmann; Miles Herkenham
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-04-21       Impact factor: 5.067

Review 3.  The movers and shapers in immune privilege of the CNS.

Authors:  Britta Engelhardt; Peter Vajkoczy; Roy O Weller
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

Review 4.  Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus.

Authors:  Meggan Mackay
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 5.  The Role of Checkpoint Inhibitors in Glioblastoma.

Authors:  Kunal Desai; Anne Hubben; Manmeet Ahluwalia
Journal:  Target Oncol       Date:  2019-08       Impact factor: 4.493

Review 6.  Immunosenescence of microglia and macrophages: impact on the ageing central nervous system.

Authors:  Khalil S Rawji; Manoj K Mishra; Nathan J Michaels; Serge Rivest; Peter K Stys; V Wee Yong
Journal:  Brain       Date:  2016-01-29       Impact factor: 13.501

Review 7.  Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

Authors:  Antoine Louveau; Sandro Da Mesquita; Jonathan Kipnis
Journal:  Neuron       Date:  2016-09-07       Impact factor: 17.173

8.  Modern cerebrospinal fluid flow research and Heinrich Quincke's seminal 1872 article on the distribution of cinnabar in freely moving animals.

Authors:  Helene Benveniste; Patrick R Hof; Maiken Nedergaard; Karl Bechter
Journal:  J Comp Neurol       Date:  2015-05-12       Impact factor: 3.215

Review 9.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

Review 10.  How do immune cells support and shape the brain in health, disease, and aging?

Authors:  Michal Schwartz; Jonathan Kipnis; Serge Rivest; Alexandre Prat
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.